SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001213900-22-057184
Filing Date
2022-09-20
Accepted
2022-09-20 09:18:17
Documents
1
Effectiveness Date
2022-09-20

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 ea166038-s8pos_inmedpharma.htm S-8 POS 77961
  Complete submission text file 0001213900-22-057184.txt   78973
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-8 POS | Act: 33 | File No.: 333-260323 | Film No.: 221252183
SIC: 2834 Pharmaceutical Preparations